Co-Diagnostics, Inc. (CODX)

1,1100 -0,0300 (-2,63%) Börsenschluss: 04:00PM EDT

Co-Diagnostics, Inc.

2401 South Foothill Drive
Suite D
Salt Lake City, UT 84109
United States
(801) 438-1036
https://www.codiagnostics.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 155

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Dwight H. Egan	Chairman & CEO	415,75k	N/A	1953
Mr. Brian L. Brown CPA	CFO & Company Secretary	338,92k	N/A	1976
Mr. Richard David Abbott	President	N/A	N/A	1972
Dr. Brent C. Satterfield Ph.D.	Co-Founder & Member of Scientific Advisory Board	237,5k	N/A	1977
Mr. David Nielsen	Chief Operating Officer	N/A	N/A	N/A
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting	N/A	N/A	N/A
Mr. Christopher Thurston	Chief Technology Officer	N/A	N/A	N/A
Dr. Mark Poritz Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Mr. Andrew Benson	Head of Investor Relations	N/A	N/A	N/A
Dr. Mayuranki Almaula	Senior Vice President of Overseas Operations & Strategic Alliances	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Co-Diagnostics, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 9. Die grundlegenden Scores sind Audit: 9, Vorstand: 10, Shareholderrechte: 5, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.